Journal
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
Volume 25, Issue 4, Pages 491-501Publisher
MARCEL DEKKER INC
DOI: 10.1081/IPH-120026435
Keywords
Bojungikki-tang; chronic fatigue syndrome; lipopolysaccharide; cytokines
Categories
Ask authors/readers for more resources
Bojungikki-tang (BIT) has been widely used to treat patients suffering from chronic fatigue syndrome (CFS). However, its effect has not been yet investigated experimentally. Based upon the clinical presentation of CFS, we hypothesized that cytokines may play a role in the pathogenesis of the disease. We studied the effect of BIT on lipopolysaccharide (LPS)-induced various cytokines production in peripheral blood mononuclear cells (PBMC) of CFS patients. Bojungikki-tang (1 mg/mL) significantly inhibited LPS-induced tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-10, transforming growth factor (TNF)-beta1 production by 63.55% +/- 0.19%, 55.06% +/- 0.27%, 48.23% +/- 0.48%, 54.09% +/- 0.76%, respectively (P < 0.05). Bojungikki-tang showed a slightly lower inhibitory effect of LPS-induced Interferon (IFN)-γ production. These results suggest that BIT may be useful in treating fatigue associated with chronic diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available